Tin tức & Cập nhật
Lọc theo Chuyên ngành:
LIBERTY-UC: Maintenance subcutaneous infliximab eases moderate-to-severe UC
The subcutaneous infliximab formulation CT-P13 appears beneficial in the maintenance treatment of patients with moderately to severely active ulcerative colitis (UC), with data from the phase III study LIBERTY-UC showing that the drug outperforms placebo in multiple endpoints.
LIBERTY-UC: Maintenance subcutaneous infliximab eases moderate-to-severe UC
22 May 2023
Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC
In the third-line treatment of patients with refractory RAS wild-type metastatic colorectal cancer (MCRC), use of panitumumab plus the standard-of-care trifluridine-tipiracil appears to prolong progression-free survival (PFS) when compared with trifluridine-tipiracil alone, according to data from a phase II study.
Panitumumab plus trifluridine-tipiracil confers survival advantage in RAS wild-type MCRC
21 May 2023
Herbal combination works in treatment of active ulcerative colitis
The herbal combination of curcumin plus QingDai (CurQD) appears beneficial to patients with active ulcerative colitis (UC), with a recent study showing that the combination induced clinical and biomarker remission.
Herbal combination works in treatment of active ulcerative colitis
20 May 2023
Broad-spectrum antibiotic exposure ups risk of IBD
Exposure to broad-spectrum antibiotics may put individuals at risk of developing inflammatory bowel disease (IBD), such that the greater the dose, the higher the risk, as shown in a study.
